Largest healthcare companies by revenue — page 4
| # | Company | Revenue | YoY | 15-year trend |
|---|---|---|---|---|
| 301 | RegenxbioRGNXUS | $170M | +104.5% | |
| 302 | Ginkgo BioworksDNAUS | $170M | −25.1% | |
| 303 | MarimedMRMDUS | $160M | +1.3% | |
| 304 | LiquidiaLQDAUS | $158M | +1,031.2% | |
| 305 | Heron TherapeuticsHRTXUS | $155M | +7.4% | |
| 306 | Airsculpt TechnologiesAIRSUS | $152M | −15.8% | |
| 307 | MacrogenicsMGNXUS | $150M | −0.3% | |
| 308 | NeuroneticsSTIMUS | $149M | +99.2% | |
| 309 | Elite PharmaceuticalsELTPUS | $149M | +77.1% | |
| 310 | GrailGRALUS | $147M | +17.2% | |
| 311 | Cronos GroupCRONCA | $147M | +24.6% | |
| 312 | Karyopharm TherapeuticsKPTIUS | $146M | +0.6% | |
| 313 | Infusystem HoldingsINFUUS | $143M | +6.4% | |
| 314 | Beam TherapeuticsBEAMUS | $140M | +120.0% | |
| 315 | NRC HealthNRCUS | $137M | −4.0% | |
| 316 | RxsightRXSTUS | $134M | −3.9% | |
| 317 | Xtant MedicalXTNTUS | $134M | +14.2% | |
| 318 | RidgetechRDGTCN | $132M | +10.2% | |
| 319 | Natural Alternatives InternationalNAIIUS | $130M | +14.1% | |
| 320 | Niagen BioscienceNAGEUS | $129M | +29.9% | |
| 321 | XencorXNCRUS | $126M | +13.7% | |
| 322 | Monte Rosa TherapeuticsGLUEUS | $124M | +63.5% |
All figures from SEC filings · FY2025 · 22
see sources
- Regenxbio 0001193125-26-094013
- Ginkgo Bioworks 0001628280-26-012346
- Marimed 0001522767-26-000030
- Liquidia 0001104659-26-023804
- Heron Therapeutics 0001193125-26-073515
- Airsculpt Technologies 0001870940-26-000021
- Macrogenics 0001125345-26-000017
- Neuronetics 0001104659-26-029004
- Elite Pharmaceuticals 0001493152-26-031070
- Grail 0001628280-26-017319
- Cronos Group 0001656472-26-000016
- Karyopharm Therapeutics 0001193125-26-049397
- Infusystem Holdings 0001628280-26-012804
- Beam Therapeutics 0001193125-26-065194
- NRC Health 0001437749-26-007002
- Rxsight 0001193125-26-071775
- Xtant Medical 0001493152-26-013792
- Ridgetech 0001213900-26-083638
- Natural Alternatives International 0001437749-25-029731
- Niagen Bioscience 0001386570-26-000013
- Xencor 0001326732-26-000015
- Monte Rosa Therapeutics 0001193125-26-109360
Largest companies by revenue →